<html><head><meta name="qrichtext" content="charset=utf-8" /></head><body style="font-size:10pt;font-family:Sans">
<p>&nbsp;<br /><br /></p>
<p align="center"><span style="font-weight:600">INFECTIONS&nbsp;URINAIRES<br /></span><br /></p>
<p><span style="font-weight:600;text-decoration:underline">ATTENTION:&nbsp;</span><br />&gt;&nbsp;De&nbsp;nombreux&nbsp;germes<span style="font-weight:600">&nbsp;</span>sont<span style="font-weight:600">&nbsp;</span>résistants<span style="font-weight:600">&nbsp;</span>à:<br />	Amoxicilline<span style="font-weight:600">&nbsp;</span>(Clamoxyl®&nbsp;)<span style="font-weight:600">&nbsp;</span>et<span style="font-weight:600">&nbsp;</span>à&nbsp;I'association<br />	Amoxicilline<span style="font-weight:600">&nbsp;</span>+&nbsp;Acide<span style="font-weight:600">&nbsp;</span>Clavulanlque<span style="font-weight:600">&nbsp;</span>(Augmentin®.<span style="font-weight:600">&nbsp;<br /></span>&gt;&nbsp;Les<span style="font-weight:600">&nbsp;</span>fluoroquinolones<span style="font-weight:600">&nbsp;</span>(Péflacine®,<span style="font-weight:600">&nbsp;</span>Ciflox®,<span style="font-weight:600">&nbsp;</span>Oflocet®,&nbsp;Logiflox®,<span style="font-weight:600">&nbsp;</span>Uniflox®,<span style="font-weight:600">&nbsp;</span>Noroxine®),<span style="font-weight:600">&nbsp;<br /></span>	largement<span style="font-weight:600">&nbsp;</span>utilisees<span style="font-weight:600">&nbsp;</span>dans<span style="font-weight:600">&nbsp;</span>le<span style="font-weight:600">&nbsp;</span>traitement<span style="font-weight:600">&nbsp;</span>des<span style="font-weight:600">&nbsp;</span>infections<span style="font-weight:600">&nbsp;</span>urinaires<span style="font-weight:600">&nbsp;</span>sont&nbsp;<span style="font-weight:600">contre-indiquées&nbsp;</span>chez<span style="font-weight:600">&nbsp;</span>les<span style="font-weight:600">&nbsp;	femmes&nbsp;enceintes&nbsp;et&nbsp;les&nbsp;enfants&nbsp;jusqu'à&nbsp;20&nbsp;ans&nbsp;</span>!!!I<span style="font-weight:600">&nbsp;<br /></span><br />Les<span style="font-weight:600">&nbsp;</span>fluoroquinolones&nbsp;doivent<span style="font-weight:600">&nbsp;</span>être<span style="font-weight:600">&nbsp;</span>prescrites<span style="font-weight:600">&nbsp;</span>Per<span style="font-weight:600">&nbsp;</span>Os.<br /><br /><span style="font-weight:600;text-decoration:underline">1)&nbsp;Ia&nbsp;Cystite&nbsp;Aigüe&nbsp;de&nbsp;Ia&nbsp;femme</span><span style="font-weight:600"><br /></span><br />-&nbsp;<span style="font-weight:600">Le&nbsp;diagnostic&nbsp;est&nbsp;clinique&nbsp;</span>:&nbsp;brûlures,<span style="font-weight:600">&nbsp;</span>pollakiurie,<span style="font-weight:600">&nbsp;</span>pesanteur<span style="font-weight:600">&nbsp;</span>vésicale,<span style="font-weight:600">&nbsp;</span>hématurie,<span style="font-weight:600">&nbsp;</span>T°&nbsp;&lt;&nbsp;38&quot;,<span style="font-weight:600">&nbsp;</span>absence<br />de<span style="font-weight:600">&nbsp;</span>douleur<span style="font-weight:600">&nbsp;</span>lombaire.<span style="font-weight:600">&nbsp;<br />-&nbsp;L'ECBU&nbsp;est&nbsp;inutile.&nbsp;</span>La<span style="font-weight:600">&nbsp;</span>recherche<span style="font-weight:600">&nbsp;</span>d'une<span style="font-weight:600">&nbsp;</span>leurocyturie<span style="font-weight:600">&nbsp;</span>et<span style="font-weight:600">&nbsp;</span>d'une<span style="font-weight:600">&nbsp;</span>bactériune&nbsp;(détection<span style="font-weight:600">&nbsp;</span>des<span style="font-weight:600">&nbsp;</span>nitrites)<span style="font-weight:600">&nbsp;</span>par:<span style="font-weight:600">&nbsp;<br />-&nbsp;la&nbsp;bandelette&nbsp;urinaire&nbsp;doit&nbsp;par&nbsp;contre&nbsp;être&nbsp;systématique</span>.<span style="font-weight:600">&nbsp;</span>La<span style="font-weight:600">&nbsp;</span>bandelette&nbsp;peut&nbsp;être&nbsp;négative&nbsp;en&nbsp;cas&nbsp;d'urines&nbsp;diluées,&nbsp;de&nbsp;séjour&nbsp;des&nbsp;urines&nbsp;dans&nbsp;la&nbsp;vessie&nbsp;&lt;&nbsp;4&nbsp;heures&nbsp;ou&nbsp;en&nbsp;cas&nbsp;d'infection&nbsp;par&nbsp;un&nbsp;germe&nbsp;dépourvu&nbsp;de&nbsp;nitrite-réductase&nbsp;(cocci&nbsp;Gram&nbsp;positif&nbsp;et&nbsp;bacille&nbsp;pyocianique).&nbsp;<span style="font-weight:600"><br />-&nbsp;La&nbsp;cystite&nbsp;simple&nbsp;de&nbsp;la&nbsp;femme&nbsp;jeune&nbsp;</span>peut<span style="font-weight:600">&nbsp;</span>bénéficier<span style="font-weight:600">&nbsp;</span>d'un<span style="font-weight:600">&nbsp;</span>traitement&nbsp;court&nbsp;de&nbsp;3&nbsp;jours&nbsp;ou&nbsp;même&nbsp;en&nbsp;dose&nbsp;unique.&nbsp;<br />	<span style="font-weight:600">Le&nbsp;traitement&nbsp;de&nbsp;3&nbsp;jours</span>&nbsp;	=&nbsp;Logiflox®&nbsp;Icp&nbsp;à&nbsp;400&nbsp;mg&nbsp;I&nbsp;jour.&nbsp;<br />	<span style="font-weight:600">Le&nbsp;traitement&nbsp;en&nbsp;dose&nbsp;unique</span>&nbsp;	=&nbsp;Uniflox®&nbsp;1&nbsp;cp&nbsp;			ou&nbsp;<br />					&nbsp;&nbsp;&nbsp;Péflacine&nbsp;Monodose®&nbsp;2&nbsp;cp,&nbsp;	ou&nbsp;<br />					&nbsp;&nbsp;&nbsp;Monuril®&nbsp;=&nbsp;Uridoz®&nbsp;1cp.&nbsp;<br />La&nbsp;guérison&nbsp;est&nbsp;confirmée&nbsp;par&nbsp;la&nbsp;disparition&nbsp;des&nbsp;signes&nbsp;cliniques&nbsp;et&nbsp;la&nbsp;négativité&nbsp;de&nbsp;la&nbsp;bandelette&nbsp;urinaire&nbsp;de<br />contrôle.<br /><br /><span style="font-weight:600">-&nbsp;Un&nbsp;traitement&nbsp;classique&nbsp;de&nbsp;7&nbsp;jours&nbsp;</span>et<span style="font-weight:600">&nbsp;</span>la<span style="font-weight:600">&nbsp;</span>réalisation<span style="font-weight:600">&nbsp;</span>d'une<span style="font-weight:600">&nbsp;</span>ECBU<span style="font-weight:600">&nbsp;</span>initial<span style="font-weight:600">&nbsp;</span>et<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>contrôle<span style="font-weight:600">&nbsp;</span>s'imposent<span style="font-weight:600">&nbsp;</span>en<br />cas<span style="font-weight:600">&nbsp;</span>:<br />	&gt;&nbsp;d'échec&nbsp;d'un&nbsp;traitement&nbsp;court,&nbsp;<br />	&gt;&nbsp;en&nbsp;cas&nbsp;de&nbsp;tare&nbsp;associée,&nbsp;<br />	&gt;&nbsp;chez&nbsp;les&nbsp;femmes&nbsp;<span style="font-weight:600">de&nbsp;plus&nbsp;de&nbsp;65&nbsp;ans&nbsp;</span><br />	&gt;&nbsp;chez<span style="font-weight:600">&nbsp;</span>les<span style="font-weight:600">&nbsp;femmes&nbsp;enceinte</span>.<span style="font-weight:600">&nbsp;<br /><br /></span>-&nbsp;Chez&nbsp;les&nbsp;femmes&nbsp;agées&nbsp;et&nbsp;les&nbsp;patients&nbsp;sondés,&nbsp;les&nbsp;bactériuries&nbsp;asymptomatiques<span style="font-weight:600">&nbsp;</span>ne<span style="font-weight:600">&nbsp;</span>doivent<span style="font-weight:600">&nbsp;</span>pas<span style="font-weight:600">&nbsp;</span>être<span style="font-weight:600">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>traitées.<span style="font-weight:600">&nbsp;<br /><br /></span>-&nbsp;A&nbsp;I'inverse<span style="font-weight:600">&nbsp;</span>chez<span style="font-weight:600">&nbsp;</span>les<span style="font-weight:600">&nbsp;</span>femmes<span style="font-weight:600">&nbsp;</span>enceintes<span style="font-weight:600">&nbsp;</span>toutes<span style="font-weight:600">&nbsp;</span>les&nbsp;bactériuries<span style="font-weight:600">&nbsp;</span>doivent<span style="font-weight:600">&nbsp;</span>être<span style="font-weight:600">&nbsp;</span>traitées<span style="font-weight:600">&nbsp;</span>systématiquement.<span style="font-weight:600">&nbsp;<br /></span>&nbsp;&nbsp;Chez<span style="font-weight:600">&nbsp;</span>les<span style="font-weight:600">&nbsp;</span>femmes<span style="font-weight:600">&nbsp;</span>enceintes<span style="font-weight:600">&nbsp;</span>seules<span style="font-weight:600">&nbsp;</span>les&nbsp;bétalactamines<span style="font-weight:600">&nbsp;</span>sont<span style="font-weight:600">&nbsp;</span>utilisables.<span style="font-weight:600">&nbsp;<br /><br /></span>-&nbsp;Pour<span style="font-weight:600">&nbsp;</span>les<span style="font-weight:600">&nbsp;</span>autres<span style="font-weight:600">&nbsp;</span>patients,<span style="font-weight:600">&nbsp;</span>utiliser<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>préférence:	Noroxine®<span style="font-weight:600">&nbsp;</span>(2<span style="font-weight:600">&nbsp;</span>cp<span style="font-weight:600">&nbsp;</span><span style="font-style:italic">I&nbsp;</span>jour)<span style="font-weight:600">&nbsp;</span>ou<span style="font-weight:600">&nbsp;</span>le<span style="font-weight:600">&nbsp;<br />						</span>Bactrim<span style="font-weight:600">&nbsp;</span>Forte®<span style="font-weight:600">&nbsp;</span>(2<span style="font-weight:600">&nbsp;</span>cp<span style="font-weight:600">&nbsp;</span>matin<span style="font-weight:600">&nbsp;</span>et<span style="font-weight:600">&nbsp;</span>soir)<span style="font-weight:600">&nbsp;</span>en<span style="font-weight:600">&nbsp;</span>2ème<span style="font-weight:600">&nbsp;</span>intention.<br />-&nbsp;Les<span style="font-weight:600">&nbsp;</span>cystites<span style="font-weight:600">&nbsp;</span>aigues&nbsp;récidivantes<span style="font-weight:600">&nbsp;</span>peuvent<span style="font-weight:600">&nbsp;</span>bénéficier<span style="font-weight:600">&nbsp;</span>d'un<span style="font-weight:600">&nbsp;</span>traitement<span style="font-weight:600">&nbsp;</span>court<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>chaque<span style="font-weight:600">&nbsp;</span>épisode.<br />&nbsp;&nbsp;En<span style="font-weight:600">&nbsp;</span>fonction<span style="font-weight:600">&nbsp;</span>de<span style="font-weight:600">&nbsp;</span>la<span style="font-weight:600">&nbsp;</span>fréquence<span style="font-weight:600">&nbsp;</span>des<span style="font-weight:600">&nbsp;</span>récidives&nbsp;(&lt;&nbsp;ou&nbsp;&gt;&nbsp;4&nbsp;par&nbsp;an)&nbsp;un<span style="font-weight:600">&nbsp;</span>traitement<span style="font-weight:600">&nbsp;</span>préventif<span style="font-weight:600">&nbsp;</span>est<span style="font-weight:600">&nbsp;</span>associé.<br />&nbsp;&nbsp;Dans<span style="font-weight:600">&nbsp;</span>tous<span style="font-weight:600">&nbsp;</span>les<span style="font-weight:600">&nbsp;</span>cas<span style="font-weight:600">&nbsp;</span>un<span style="font-weight:600">&nbsp;</span>bilan<span style="font-weight:600">&nbsp;</span>urologique<span style="font-weight:600">&nbsp;</span>s'impose.<br /><br /><span style="font-weight:600;text-decoration:underline">2)&nbsp;Cystite&nbsp;Aigue&nbsp;de&nbsp;I'homme</span><span style="font-weight:600"><br /></span><br />La&nbsp;cystite&nbsp;de&nbsp;I'homme&nbsp;n'est&nbsp;jamais&nbsp;&quot;banale&quot;.&nbsp;Une&nbsp;prostatite&nbsp;associée&nbsp;doit&nbsp;toujours&nbsp;être&nbsp;recherchée<br />=&gt;&nbsp;TR.&nbsp;L'ECBU&nbsp;initial&nbsp;et&nbsp;la&nbsp;réalisation&nbsp;d'un&nbsp;bilan&nbsp;urologique&nbsp;sont&nbsp;indispensables.&nbsp;Le&nbsp;traitement&nbsp;doit<br />être&nbsp;prolongé&nbsp;:&nbsp;2&nbsp;à&nbsp;3&nbsp;semaines&nbsp;en&nbsp;cas&nbsp;d'infection&nbsp;vésicale&nbsp;isolée,&nbsp;1&nbsp;à&nbsp;3&nbsp;mois&nbsp;en&nbsp;cas&nbsp;de&nbsp;prostatite<br />associée.&nbsp;Les&nbsp;fluoroquinolones&nbsp;Sont&nbsp;utilisées&nbsp;en&nbsp;première&nbsp;intention.<br /><br /><span style="font-weight:600;text-decoration:underline">3)&nbsp;Prostatite&nbsp;Aigue</span><span style="font-weight:600"><br /></span><br />Le&nbsp;tableau&nbsp;clinique&nbsp;associe&nbsp;des&nbsp;troubles&nbsp;urinaires,&nbsp;de&nbsp;la&nbsp;fiévre&nbsp;et&nbsp;une&nbsp;douleur&nbsp;au&nbsp;TR.&nbsp;II&nbsp;existe&nbsp;un<br />risque&nbsp;de&nbsp;rétention&nbsp;aigue&nbsp;d'urine.&nbsp;Le&nbsp;<span style="text-decoration:underline">sondage&nbsp;est&nbsp;INTERDIT</span>.&nbsp;L'enquète&nbsp;bactériologique&nbsp;repose&nbsp;sur<br />I'ECBU,&nbsp;le&nbsp;prélèvement&nbsp;urétéral&nbsp;et&nbsp;les&nbsp;hémocultures.&nbsp;Le&nbsp;traitement&nbsp;est&nbsp;une&nbsp;bi-antibiothérapie&nbsp;:<br />fluoroquinolone&nbsp;+&nbsp;aminoside&nbsp;ou&nbsp;C3G&nbsp;+&nbsp;aminoside,&nbsp;a&nbsp;laquelle&nbsp;on&nbsp;associe&nbsp;des&nbsp;AINS,&nbsp;des&nbsp;bains&nbsp;de<br />siège,&nbsp;du&nbsp;repos&nbsp;et&nbsp;des&nbsp;laxatifs.<br /><br /><span style="font-weight:600;text-decoration:underline">4)&nbsp;Pyélonéphrite&nbsp;Aigue</span><span style="font-weight:600"><br /></span><br />-Toutes&nbsp;les&nbsp;infections&nbsp;urinaires&nbsp;fébriles&nbsp;doivent&nbsp;bénéficier&nbsp;en&nbsp;urgences&nbsp;d'une&nbsp;bandelette&nbsp;urinaire,&nbsp;d'une<br />&nbsp;&nbsp;ECBU,&nbsp;de&nbsp;3&nbsp;hémocultures&nbsp;rapprochées,&nbsp;d'1&nbsp;ASP&nbsp;et&nbsp;d'une&nbsp;échographie.&nbsp;Le&nbsp;traitement&nbsp;doit&nbsp;être<br />&nbsp;&nbsp;débuté&nbsp;dès&nbsp;la&nbsp;fin&nbsp;des&nbsp;prélévements.<br />-&nbsp;Lorsque&nbsp;le&nbsp;tableau&nbsp;dinique&nbsp;est&nbsp;typique&nbsp;chez&nbsp;une&nbsp;femme&nbsp;jeune&nbsp;non&nbsp;tarée&nbsp;un&nbsp;traitement&nbsp;de&nbsp;10&nbsp;jours<br />&nbsp;&nbsp;par&nbsp;fluoroquinolone&nbsp;per&nbsp;os&nbsp;est&nbsp;suffisant.&nbsp;Si&nbsp;les&nbsp;examens&nbsp;bactériologiques&nbsp;sont&nbsp;négatifs&nbsp;un<br />&nbsp;&nbsp;uroscanner&nbsp;doit&nbsp;être&nbsp;pratiqué&nbsp;dés&nbsp;le&nbsp;lendemain.<br />-&nbsp;Si&nbsp;il&nbsp;s'agit&nbsp;d'un&nbsp;patient&nbsp;agé&nbsp;ou&nbsp;taré,&nbsp;d'un&nbsp;homme,&nbsp;d'un&nbsp;sujet&nbsp;porteur&nbsp;d'une&nbsp;anomalie&nbsp;urinaire,&nbsp;ou&nbsp;si&nbsp;la<br />&nbsp;&nbsp;fièvre&nbsp;ne&nbsp;céde&nbsp;pas&nbsp;en&nbsp;36&nbsp;heures,&nbsp;il&nbsp;s'agit&nbsp;d'une&nbsp;pyélonéphrite&nbsp;compliquée&nbsp;=&gt;&nbsp;bi-antibiothérapie&nbsp;:<br />&nbsp;&nbsp;fluoroquinolone&nbsp;+&nbsp;aminoside&nbsp;ou&nbsp;C3G&nbsp;+&nbsp;aminoside&nbsp;et&nbsp;hospitalisation&nbsp;en&nbsp;Urologie.<br /><br />SAU&nbsp;NORD&nbsp;Novembre&nbsp;1999<br /></p>
</body></html>
